Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy - Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian; Boch, Tobias; Michaeli, Julia (The European journal of health economics, 2024)
Online veröffentlicht: 14. November 2023